A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

NCT04640025 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis
Postlung Transplant (Bronchiolitis Obliterans)
Chronic Graft Versus Host Disease

Interventions

DRUG: itacitinib

Sponsor

Incyte Corporation